Academic · Private company
Baylor College of Medicine
Track this companyFree. Adds Baylor College of Medicine to your Dealase workspace and tells you when its record changes.
Clinical trials2525 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials25
- Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's DiseaseNA · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT06835283 · fetched Nov 12, 2026
- Transcutaneous Vagus Nerve Stimulation for Attention and MemoryNA · NOT_YET_RECRUITING · started Dec 1, 2026ClinicalTrials.gov NCT06723743 · fetched Nov 12, 2026
- Cortical rTMS as a Treatment for DepressionNA · RECRUITING · started Nov 1, 2026ClinicalTrials.gov NCT05487911 · fetched Nov 12, 2026
- PATHS-UP Health Behavior Self-monitoring Mobile App for AdolescentsNA · RECRUITING · started Apr 30, 2025ClinicalTrials.gov NCT06959901 · fetched Nov 12, 2026
- Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic AdolescentsNA · RECRUITING · started Apr 12, 2025ClinicalTrials.gov NCT06943001 · fetched Nov 12, 2026
- Intrathecal Baclofen and Pediatric DystoniaNA · RECRUITING · started Nov 1, 2024ClinicalTrials.gov NCT06606574 · fetched Nov 12, 2026
- Novel Bipolar Radiofrequency Ablation Knife in Esophageal LesionsRECRUITING · started Oct 15, 2024ClinicalTrials.gov NCT06476678 · fetched Nov 12, 2026
- Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 DepletionNA · ACTIVE_NOT_RECRUITING · started Dec 6, 2023ClinicalTrials.gov NCT05236764 · fetched Nov 12, 2026
- Fetal Repair of Complex Gastroschisis: A Safety and Feasibility TrialNA · RECRUITING · started Oct 20, 2023ClinicalTrials.gov NCT05704257 · fetched Nov 12, 2026
- Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic CancerPHASE2 · RECRUITING · started Aug 31, 2022ClinicalTrials.gov NCT05132504 · fetched Nov 12, 2026
- Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708ACTIVE_NOT_RECRUITING · started Aug 1, 2022ClinicalTrials.gov NCT05317637 · fetched Nov 12, 2026
- TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.PHASE1 · RECRUITING · started Mar 8, 2021ClinicalTrials.gov NCT04013802 · fetched Nov 12, 2026
- Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 AntigenPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 9, 2020ClinicalTrials.gov NCT04219163 · fetched Nov 12, 2026
- High Dose Albumin in Refractory AscitesPHASE2 · RECRUITING · started Mar 25, 2019ClinicalTrials.gov NCT05867602 · fetched Nov 12, 2026
- GD2 Specific CAR and Interleukin-15 Expressing Autologous NKT Cells to Treat Children With NeuroblastomaPHASE1 · ACTIVE_NOT_RECRUITING · started Jan 18, 2018ClinicalTrials.gov NCT03294954 · fetched Nov 12, 2026
- Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 AntigenPHASE1 · ACTIVE_NOT_RECRUITING · started Nov 1, 2017ClinicalTrials.gov NCT03081910 · fetched Nov 12, 2026
- Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple MyelomaPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 1, 2015ClinicalTrials.gov NCT02291848 · fetched Nov 12, 2026
- Activated T Lymphocytes Expressing CARs, Relapsed CD19+ Malignancies Post-Allo HSCT(CARPASCIO)PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 1, 2014ClinicalTrials.gov NCT02050347 · fetched Nov 12, 2026
- Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)PHASE1 · RECRUITING · started Feb 1, 2014ClinicalTrials.gov NCT01853631 · fetched Nov 12, 2026
- Administration of Donor T Cells With the Caspase-9 Suicide GenePHASE1 · ACTIVE_NOT_RECRUITING · started Nov 1, 2011ClinicalTrials.gov NCT01494103 · fetched Nov 12, 2026
- Allogeneic Tumor Cell Vaccination With Oral Metronomic Cytoxan in Patients With High-Risk NeuroblastomaPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Sep 1, 2010ClinicalTrials.gov NCT01192555 · fetched Nov 12, 2026
- Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALLPHASE1 · ACTIVE_NOT_RECRUITING · started Jul 1, 2009ClinicalTrials.gov NCT00881920 · fetched Nov 12, 2026
- Multi-virus CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRATPHASE1 · ACTIVE_NOT_RECRUITING · started Apr 1, 2009ClinicalTrials.gov NCT00840853 · fetched Nov 12, 2026
- CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLLPHASE1 · ACTIVE_NOT_RECRUITING · started Feb 1, 2009ClinicalTrials.gov NCT00586391 · fetched Nov 12, 2026
- Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)PHASE1 · ACTIVE_NOT_RECRUITING · started Apr 1, 2006ClinicalTrials.gov NCT00368082 · fetched Nov 12, 2026